impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

One year in review

 

Novel insights into the management of rheumatoid arthritis: one year in review 2023

1, 2, 3, 4, 5, 6, 7, 8, 9, 10

 

  1. Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Cona, Ferrara, Italy.
  2. Rheumatology Division, Multi-specialist Medical Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  3. Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Cona, Ferrara, Italy.
  4. Rheumatology Department, IRCCS Ospedale Galeazzi - Sant’Ambrogio, Milan, Italy.
  5. Rheumatology Unit, Department of Medicine, University of Padova, Italy.
  6. Department of Internal Medicine and Medical Therapy, University of Pavia; and Istituti Clinici Scientifici Maugeri IRCCS Pavia, Italy.
  7. Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna, Cona, Ferrara, Italy.
  8. Rheumatology Department, IRCCS Ospedale Galeazzi - Sant’Ambrogio, Milan, Italy.
  9. Rheumatology Division, Multi-specialist Medical Department, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  10. School of Medicine and Surgery, University of Milano-Bicocca, Milan; and Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy. carlo.scire@unimib.it

CER16723
2023 Vol.41, N°11
PI 2129, PF 2141
One year in review

Free to view
(click on article PDF icon to read the article)

PMID: 37497719 [PubMed]

Received: 02/04/2023
Accepted : 26/06/2023
In Press: 24/07/2023
Published: 14/11/2023

Abstract

New evidence from 2022 slightly changed some perspectives for rheumatoid arthritis (RA) management. Real-world data on the efficacy and safety of disease-modifying anti-rheumatic drugs strengthened the importance of tailoring treatment decisions based on patient characteristics. Moreover, the research of response biomarkers to therapy underlined the need for precision medicine and remote care applications showed an innovative outlook that supports a patient-centred approach. New developments in vaccinations led to the release of updated guidelines and to a consistent improvement in the prevention of vaccine-preventable infections. New literature data also reconsidered drug management in RA-associated interstitial lung disease and pregnancy. In this paper, the reviewers aim to present the most relevant studies published during the last year in the field of RA management.

DOI: https://doi.org/10.55563/clinexprheumatol/nat8nl

Rheumatology Article